Gossypol

Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Gossypol?

Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gossypol

MeSH term MeSH ID Detail
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Proteinuria D011507 30 associated lipids
Genital Neoplasms, Male D005834 3 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Protein Deficiency D011488 5 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Per page 10 20 50 100 | Total 52

PubChem Associated disorders and diseases

What pathways are associated with Gossypol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Gossypol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Gossypol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Gossypol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Gossypol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Gossypol?

Xenograft Model

Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).

Transgenic Model

Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Gossypol

Download all related citations
Per page 10 20 50 100 | Total 1511
Authors Title Published Journal PubMed Link
Lin YL et al. Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells. 2013 Mol. Pharm. pmid:23734725
Pond GR et al. Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trials. 2013 Urol. Oncol. pmid:22552048
Hamdy R et al. Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents. 2013 Bioorg. Med. Chem. Lett. pmid:23474389
Yuan Y et al. Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells. 2013 Cell Death Dis pmid:23807219
Deng S et al. Gossypol acetic acid induces apoptosis in RAW264.7 cells via a caspase-dependent mitochondrial signaling pathway. 2013 J. Vet. Sci. pmid:23820203
Zhan YH et al. Growth inhibition and apoptosis induction of human umbilical vein endothelial cells by apogossypolone. 2013 Asian Pac. J. Cancer Prev. pmid:23679275
Mellon JE et al. Effects of temperature and medium composition on inhibitory activities of gossypol-related compounds against aflatoxigenic fungi. 2013 J. Appl. Microbiol. pmid:23594138
Cho H et al. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer. 2013 J Control Release pmid:23246471
Ahn JH et al. Defective autophagy in multidrug resistant cells may lead to growth inhibition by BH3-mimetic gossypol. 2013 J. Cell. Physiol. pmid:23254564
Zhang Z et al. Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach. 2013 Eur J Med Chem pmid:23220642
Zhou M et al. Metabolic engineering of gossypol in cotton. 2013 Appl. Microbiol. Biotechnol. pmid:23775273
Song B et al. Gossypol suppresses mouse T lymphocytes via inhibition of NFκB, NFAT and AP-1 pathways. 2013 Immunopharmacol Immunotoxicol pmid:23981004
Billard C BH3 mimetics: status of the field and new developments. 2013 Mol. Cancer Ther. pmid:23974697
Guo JY et al. Effects of high-gossypol cotton on the development and reproduction of Bemisia tabaci (Hemiptera: Aleyrodidae) MEAM1 cryptic species. 2013 J. Econ. Entomol. pmid:23865205
Zhang Z et al. Design and application of a rigid quinazolone scaffold based on two-face Bim α-helix mimicking. 2013 Eur J Med Chem pmid:24095762
Semon B Dietary intake of cottonseed toxins is hypothesized to be a partial cause of Alzheimer's disorder. 2012 Med. Hypotheses pmid:22136946
Pond GR et al. Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer. 2012 Clin Genitourin Cancer pmid:23000202
Ilkevych NS et al. Vibrational spectra, structure and antioxidant activity of gossypol imine derivatives. 2012 Spectrochim Acta A Mol Biomol Spectrosc pmid:22078080
Azab B et al. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells. 2012 J. Cell. Physiol. pmid:21780116
Rathore KS et al. Ultra-low gossypol cottonseed: generational stability of the seed-specific, RNAi-mediated phenotype and resumption of terpenoid profile following seed germination. 2012 Plant Biotechnol. J. pmid:21902797
Mazumder S et al. Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells. 2012 Cancer Res. pmid:22525702
El-Mokadem MY et al. Alleviation of reproductive toxicity of gossypol using selenium supplementation in rams. 2012 J. Anim. Sci. pmid:22585803
Cheng W et al. [Effects of gossypol acetate on apoptosis in primary cultured cells from patients with lymphoid leukemia and its synergy with dexamethasone]. 2012 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22541072
Zhang YS et al. Gossypol exhibits a strong influence towards UDP-glucuronosyltransferase (UGT) 1A1, 1A9 and 2B7-mediated metabolism of xenobiotics and endogenous substances. 2012 Molecules pmid:22543504
Zubair H et al. Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage. 2012 Eur J Pharm Sci pmid:22554693
Yang X et al. Identification and proteomic analysis of a novel gossypol-degrading fungal strain. 2012 J. Sci. Food Agric. pmid:22002592
Mellon JE et al. Inhibitory effects of gossypol, gossypolone, and apogossypolone on a collection of economically important filamentous fungi. 2012 J. Agric. Food Chem. pmid:22324794
Özdoğan M et al. Effect of gossypol on blood serum parameters and small intestinal morphology of male broilers. 2012 J Anim Physiol Anim Nutr (Berl) pmid:21261752
Ionov M et al. Stability and antioxidant activity of gossypol derivative immobilized on N-polyvinylpyrrolidone. 2012 Int. J. Biol. Macromol. pmid:22910577
Chien CC et al. The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells. 2012 J. Cell. Physiol. pmid:22170686
Masood A et al. Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner. 2012 Br. J. Haematol. pmid:22171982
Lian J et al. Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation. 2012 Mol. Cancer Ther. pmid:22188816
Li HQ et al. Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein. 2012 Bioorg. Med. Chem. pmid:22739087
Ignatova M et al. Quaternized chitosan-coated nanofibrous materials containing gossypol: preparation by electrospinning, characterization and antiproliferative activity towards HeLa cells. 2012 Int J Pharm pmid:22728261
Sun P et al. Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells. 2012 Oncol. Rep. pmid:22766741
Lin H et al. A validated HPLC assay for the determination of R-(-)-gossypol in human plasma and its application in clinical pharmacokinetic studies. 2012 J Pharm Biomed Anal pmid:22483642
Billard C Development of Noxa-like BH3 mimetics for apoptosis-based therapeutic strategy in chronic lymphocytic leukemia. 2012 Mol. Cancer Res. pmid:22466256
An T et al. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1. 2012 Antiviral Res. pmid:22426469
Tao XY et al. Gossypol-enhanced P450 gene pool contributes to cotton bollworm tolerance to a pyrethroid insecticide. 2012 Mol. Ecol. pmid:22515600
Wagner TA et al. Hemigossypol, a constituent in developing glanded cottonseed (Gossypium hirsutum). 2012 J. Agric. Food Chem. pmid:22369216
Kisim A et al. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. 2012 J. Cancer Res. Clin. Oncol. pmid:22411600
Bodur C and Basaga H Bcl-2 inhibitors: emerging drugs in cancer therapy. 2012 Curr. Med. Chem. pmid:22414090
Hsiao WT et al. Involvement of Smac, p53, and caspase pathways in induction of apoptosis by gossypol in human retinoblastoma cells. 2012 Mol. Vis. pmid:22876131
Sarwar Gilani G et al. Impact of antinutritional factors in food proteins on the digestibility of protein and the bioavailability of amino acids and on protein quality. 2012 Br. J. Nutr. pmid:23107545
Vshivkov S et al. Capillary electrophoresis to quantitate gossypol enantiomers in cotton flower petals and seed. 2012 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23122406
Zbidah M et al. Gossypol-induced suicidal erythrocyte death. 2012 Toxicology pmid:23041711
Thakur A et al. Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells. 2012 PLoS ONE pmid:23185240
Jackson RS et al. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer. 2012 Neoplasia pmid:22904682
Hu W et al. Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. 2012 J. Biol. Chem. pmid:22052903
Shen Y and Ye D Re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9. 2012 Eur. Urol. pmid:21824719